P. Richelle Parham's most recent trade in Laboratory Corp. Of America Holdings was a trade of 897 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2026 | 897 | 773 | - | - | Restricted Stock Unit | |
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2026 | 897 | 3,366 (0%) | 0% | - | Common Stock | |
| Labcorp | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2026 | 773 | 1,670 | - | - | Restricted Stock Unit | |
| Labcorp | Richelle P. Parham | Director | Sale of securities on an exchange or to another person at price $ 254.28 per share. | 31 Oct 2025 | 7,009 | 2,469 (0%) | 0% | 254.3 | 1,782,273 | Common Stock |
| Best Buy | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 2,946 | 23,450 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 897 | 897 | - | - | Restricted Stock Unit | |
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 0 | - | - | Restricted Stock Unit | |
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 944 | 9,478 (0%) | 0% | - | Common Stock | |
| Best Buy | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 2,258 | 19,549 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 8,534 (0%) | 0% | - | Common Stock | |
| Labcorp | Parham P. Richelle | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 947 | 944 | - | - | Restricted Stock Unit | |
| Labcorp | P. Richelle Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 944 | 1,891 | - | - | Restricted Stock Unit | |
| Best Buy | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 2,545 | 16,500 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 849 | - | - | Restricted Stock Unit | |
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 742 | 7,587 (0%) | 0% | - | Common Stock | |
| Labcorp | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 849 | 1,591 | - | - | Restricted Stock Unit | |
| Best Buy | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 2,603 | 13,270 (0%) | 0% | 0 | Common Stock | |
| Labcorp | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 742 | 742 | - | - | Restricted Stock Unit | |
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 771 | 6,845 (0%) | 0% | - | Common Stock | |
| Labcorp | Richelle P. Parham | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 771 | 0 | - | - | Restricted Stock Unit | |
| e.l.f. Beauty Inc | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2021 | 4,662 | 34,940 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| Best Buy | Richelle P. Parham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 1,775 | 10,366 (0%) | 0% | 0 | Common Stock |